Screener
Aclaris Therapeutics ACRS Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Contract Research | $356K-19.5% | $537K+20.7% | —— | —— | $442K-30.4% | |
| Dermatology Therapeutics | $1.27M-4.6% | $1.46M+44.5% | $795K-90.8% | $2.81M-24.0% | $1.34M-37.6% |
FAQ
- How does Aclaris Therapeutics break its business down?
- Aclaris Therapeutics (ACRS) reports revenue by product across 2 parts — Contract Research and Dermatology Therapeutics. Each is extracted from the segment footnotes and tracked over time.
- Where does Aclaris Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Aclaris Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
